Active, not recruitingPhase 1NCT04896853

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NextCell Pharma Ab
Principal Investigator
Mathias Svahn, PhD
NextCell Pharma
Intervention
ProTrans®(biological)
Enrollment
9 enrolled
Eligibility
18 years · All sexes
Timeline
20212027

Study locations (1)

Collaborators

Karolinska Trial Alliance

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04896853 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials